SIA "Vorwarts Pharma"Active
Key figures
Ratios
2025Balance sheet structure
Dividends
from the reportDividends paid 63 000 € (<1% of equity at the end of the previous year).
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 30 440 | 4 549 055 | 8 300 939 | 12 535 178 | 19 646 252 | 24 909 687 | 21 648 713 |
| Total non-current assets | 0 | 0 | 2634 | 3822 | 7543 | 13 995 | 1 982 841 |
| Total assets | 30 440 | 4 549 055 | 8 303 573 | 12 539 000 | 19 653 795 | 24 923 682 | 23 631 554 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 41 110 | 1 959 386 | 848 656 | 377 362 | 2 580 322 | 1 586 294 | 2 908 311 |
| Non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 42 463 |
| Total liabilities | 41 110 | 1 959 386 | 848 656 | 377 362 | 2 580 322 | 1 586 294 | 2 950 774 |
| Share capital | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — |
| Profit for the year | -13 470 | 2 600 339 | 4 865 248 | 4 706 721 | 4 961 835 | 6 263 915 | 7 095 024 |
| Total equity | -10 670 | 2 589 669 | 7 454 917 | 12 161 638 | 17 073 473 | 23 337 388 | 20 680 780 |
| Income statement | |||||||
| Sales revenue | 0 | 5 825 084 | 10 488 381 | 10 586 214 | 11 543 595 | 13 525 764 | 30 376 831 |
| Operating profit | -13 470 | 2 600 339 | 4 865 248 | 4 706 721 | 4 939 573 | 6 180 718 | 7 070 248 |
| Profit before income tax | -13 470 | 2 600 339 | 4 865 248 | 4 706 721 | 4 974 390 | 6 269 425 | 7 106 081 |
| Profit for the reporting year | -13 470 | 2 600 339 | 4 865 248 | 4 706 721 | 4 961 835 | 6 263 915 | 7 095 024 |
| Labour costs | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — |
| Other indicators | |||||||
| Employees | 2 | 2 | 3 | 4 | 5 | 5 | 176 |
| Calculated dividend | — | 0 | 0 | 0 | 50 000 | 0 | 63 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Related companies
- MID BALTIC REALTY LIMITED filiāle
- SIA "SPIRE BALTIC"
- EASTERN EUROPEAN REALTY LIMITED filiāle
- Juridiskais birojs "KRŪMIŅŠ UN PARTNERI" , SIA
- "KMP Consulting Group" SIA
- Sabiedrība ar ierobežotu atbildību "ĀDAŽU PĻAVAS"
- SIA "Dzirnavu 114/116"
- SIA "GAUJAS DZINTARI"
- "MID INVEST" SIA
- Aldis Maldups ZAB SIA
- SIA NEST HOMES
Summary: SIA "Vorwarts Pharma"
Overview
SIA "Vorwarts Pharma" (reg. no. 50203197781) is a limited liability company. The company was registered in 2019 and has been in the register for 7 years. Registered address: Rīga, Krišjāņa Barona iela 15.
Financial results
Revenue in 2025 was 30 376 831 €, up 125% on the previous year (13 525 764 €). This is the company's highest revenue among the published years (2019–2025). Net profit for 2025 was 7 095 024 € (23,4% of revenue). The company was profitable in 6 of the 7 published years. In 2025 the company had 176 employees (5 a year earlier). Revenue per employee was 172 596 €. At the end of 2025, total assets were 23 631 554 € and equity 20 680 780 € (87,5% of assets).
Management and owners
The company has one board member. The sole owner of the company is a private individual.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.